Today

Agents

Chat

Arena

Discover

More

App

Prelude Therapeutics Q2 EPS USD -0.14 - PRLD News | Rallies

Prelude Therapeutics Q2 EPS USD -0.14

PRLD•2026-08-11

Prelude Therapeutics reports second-quarter results

Aug. 11 (Reuters) - Prelude Therapeutics Q2 net income USD -13.921 million.

Q2 operating expenses USD 21.158 million
Q2 income from operations USD -15.454 million

Related News

Superior Group Of Companies Facilities Extend Debt Maturity To August 2031

SGC•2026-08-11

Gold steadies after scaling two-month high; markets await inflation data

GLD•2026-08-11

Intensity Therapeutics Q2 Operating Income USD -3.084 Million

•

2026-08-11

Stardust Power appoints Ray Rivers to board, names him to audit and compensation committees

SDST•2026-08-11

Monumental Sports unveils USD 1 billion-plus Capital One Arena overhaul in Washington, D.C

COF•2026-08-11